Merz Pharma Canada, Ltd. Announces Health Canada Approval of XEOMIN® COSMETIC (Clostridium Botulinum Neurotoxin Type A (150kD), free from complexing proteins) for the Temporary Improvement in the Appearance of Moderate to Severe Glabellar Lines

Merz Pharma Canada, Ltd. Announces Health Canada Approval of XEOMIN® COSMETIC (Clostridium Botulinum Neurotoxin Type A (150kD), free from complexing proteins) for the Temporary Improvement in the Appearance of Moderate to Severe Glabellar Lines